MX2015007518A - Metodos para tratar el prurito. - Google Patents
Metodos para tratar el prurito.Info
- Publication number
- MX2015007518A MX2015007518A MX2015007518A MX2015007518A MX2015007518A MX 2015007518 A MX2015007518 A MX 2015007518A MX 2015007518 A MX2015007518 A MX 2015007518A MX 2015007518 A MX2015007518 A MX 2015007518A MX 2015007518 A MX2015007518 A MX 2015007518A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- treating pruritus
- pruritus
- treating
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Abstract
La presente invención se refiere a métodos para tratar el prurito con composiciones antipruríticas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261737488P | 2012-12-14 | 2012-12-14 | |
US13/715,625 US8637538B1 (en) | 2012-12-14 | 2012-12-14 | Methods for treatment of pruritis |
PCT/US2013/075096 WO2014093871A1 (en) | 2012-12-14 | 2013-12-13 | Methods for treating pruritus |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015007518A true MX2015007518A (es) | 2016-03-01 |
Family
ID=50935003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015007518A MX2015007518A (es) | 2012-12-14 | 2013-12-13 | Metodos para tratar el prurito. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP2931279B1 (es) |
JP (4) | JP2016506398A (es) |
KR (3) | KR20150093702A (es) |
CN (2) | CN110585209A (es) |
AU (2) | AU2013359017B2 (es) |
BR (1) | BR112015013984A2 (es) |
CA (1) | CA2892393C (es) |
HK (1) | HK1215541A1 (es) |
MX (1) | MX2015007518A (es) |
NZ (1) | NZ708371A (es) |
RU (1) | RU2015128265A (es) |
WO (1) | WO2014093871A1 (es) |
ZA (2) | ZA201504229B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI433674B (zh) | 2006-12-28 | 2014-04-11 | Infinity Discovery Inc | 環杷明(cyclopamine)類似物類 |
US20140179727A1 (en) | 2012-12-14 | 2014-06-26 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
NZ708371A (en) * | 2012-12-14 | 2020-05-29 | Trevi Therapeutics Inc | Methods for treating pruritus |
US20150359789A1 (en) * | 2014-06-13 | 2015-12-17 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
US10369147B2 (en) | 2015-06-04 | 2019-08-06 | PellePharm, Inc. | Topical formulations for delivery of hedgehog inhibitor compounds and use thereof |
TW201725041A (zh) * | 2016-01-04 | 2017-07-16 | 懷特生技新藥股份有限公司 | 治療皮膚癢之醫藥組合物 |
CN105560202B (zh) * | 2016-03-11 | 2019-05-24 | 广州玻思韬控释药业有限公司 | 一种盐酸纳布啡凝胶骨架缓释片的制备方法及应用 |
WO2017165409A1 (en) * | 2016-03-21 | 2017-09-28 | Trevi Therapeutics, Inc. | Treatment of uremic pruritus |
WO2018081273A1 (en) * | 2016-10-25 | 2018-05-03 | Trevi Therapeutics, Inc. | Treatment of prurigo nodularis |
SG11202100580UA (en) * | 2018-07-23 | 2021-02-25 | Trevi Therapeutics Inc | Treatment of chronic cough, breathlessness and dyspnea |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE291429T1 (de) * | 1996-11-25 | 2005-04-15 | Toray Industries | Mittel gegen juckreiz |
US20030054030A1 (en) * | 2001-09-13 | 2003-03-20 | Gary Gordon | Method and compositions for the treatment of pruritus |
US6703398B2 (en) * | 2001-11-26 | 2004-03-09 | Oliver Yoa-Pu Hu | Orally administered analgesic compositions containing nalbuphine |
EP3241548A1 (en) * | 2002-04-05 | 2017-11-08 | Euro-Celtique S.A. | Matrix for sustained, invariant and independent release of active compounds |
EP1763349A2 (en) * | 2004-06-03 | 2007-03-21 | Jonathan J. Burbaum | Pharmaceutical compositions for the treatment of pruritus |
WO2007025005A2 (en) * | 2005-08-24 | 2007-03-01 | Penwest Pharmaceuticals Co. | Sustained release formulations of nalbuphine |
US8394812B2 (en) | 2005-08-24 | 2013-03-12 | Penwest Pharmaceuticals Co. | Sustained release formulations of nalbuphine |
FR2963889B1 (fr) * | 2010-08-20 | 2013-04-12 | Debregeas Et Associes Pharma | Formulations a base de nalbuphine et leurs utilisations |
NZ708371A (en) * | 2012-12-14 | 2020-05-29 | Trevi Therapeutics Inc | Methods for treating pruritus |
-
2013
- 2013-12-13 NZ NZ708371A patent/NZ708371A/en unknown
- 2013-12-13 KR KR1020157015561A patent/KR20150093702A/ko not_active Application Discontinuation
- 2013-12-13 JP JP2015548006A patent/JP2016506398A/ja active Pending
- 2013-12-13 CA CA2892393A patent/CA2892393C/en active Active
- 2013-12-13 BR BR112015013984A patent/BR112015013984A2/pt not_active Application Discontinuation
- 2013-12-13 EP EP13863494.4A patent/EP2931279B1/en active Active
- 2013-12-13 CN CN201910603708.9A patent/CN110585209A/zh active Pending
- 2013-12-13 WO PCT/US2013/075096 patent/WO2014093871A1/en active Application Filing
- 2013-12-13 AU AU2013359017A patent/AU2013359017B2/en active Active
- 2013-12-13 KR KR1020217012252A patent/KR20210050585A/ko not_active Application Discontinuation
- 2013-12-13 MX MX2015007518A patent/MX2015007518A/es unknown
- 2013-12-13 RU RU2015128265A patent/RU2015128265A/ru not_active Application Discontinuation
- 2013-12-13 KR KR1020227010137A patent/KR20220044385A/ko not_active Application Discontinuation
- 2013-12-13 CN CN201380072542.3A patent/CN104981246A/zh active Pending
-
2015
- 2015-06-11 ZA ZA2015/04229A patent/ZA201504229B/en unknown
-
2016
- 2016-03-24 HK HK16103523.2A patent/HK1215541A1/zh unknown
-
2018
- 2018-08-09 AU AU2018214098A patent/AU2018214098B2/en active Active
-
2019
- 2019-04-04 JP JP2019071738A patent/JP6823857B2/ja active Active
- 2019-09-26 ZA ZA2019/06339A patent/ZA201906339B/en unknown
-
2020
- 2020-10-27 JP JP2020179395A patent/JP7072280B2/ja active Active
-
2022
- 2022-04-27 JP JP2022072885A patent/JP2022105095A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2018214098A1 (en) | 2018-08-30 |
JP2021020947A (ja) | 2021-02-18 |
EP2931279A4 (en) | 2016-05-11 |
JP2016506398A (ja) | 2016-03-03 |
EP2931279A1 (en) | 2015-10-21 |
HK1215541A1 (zh) | 2016-09-02 |
JP2019131588A (ja) | 2019-08-08 |
ZA201906339B (en) | 2021-07-28 |
RU2015128265A (ru) | 2017-01-25 |
AU2013359017B2 (en) | 2018-05-10 |
JP2022105095A (ja) | 2022-07-12 |
CA2892393C (en) | 2021-06-08 |
WO2014093871A1 (en) | 2014-06-19 |
EP2931279B1 (en) | 2024-03-20 |
JP7072280B2 (ja) | 2022-05-20 |
CN104981246A (zh) | 2015-10-14 |
JP6823857B2 (ja) | 2021-02-03 |
ZA201504229B (en) | 2021-07-28 |
KR20150093702A (ko) | 2015-08-18 |
NZ708371A (en) | 2020-05-29 |
KR20210050585A (ko) | 2021-05-07 |
KR20220044385A (ko) | 2022-04-07 |
AU2013359017A1 (en) | 2015-06-11 |
CA2892393A1 (en) | 2014-06-19 |
AU2018214098B2 (en) | 2019-04-18 |
BR112015013984A2 (pt) | 2017-07-11 |
CN110585209A (zh) | 2019-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015007518A (es) | Metodos para tratar el prurito. | |
MX2015012401A (es) | Composiciones y metodos de alterar niveles de colesterol. | |
SG11201506944WA (en) | Betaine compounds as additives for fuels | |
MX370649B (es) | Proceso para la preparacion de teneligliptina. | |
MX2016009590A (es) | Composiciones de apilimod y métodos para usar las mismas. | |
IN2013DE00266A (es) | ||
IN2014DN08777A (es) | ||
SG11201509341VA (en) | Fuel additive composition | |
IN2014CH00151A (es) | ||
EP2994542A4 (en) | Compositions for ovarian cancer assessment having improved specificity | |
PH12016501183A1 (en) | Novel compound for treatment of severe hypoglycemia | |
IN2013MU01113A (es) | ||
UA117567C2 (uk) | Композиція, яка стимулює лактацію, на основі фосфатидилсерину | |
IN2014DN10209A (es) | ||
PH12016501182A1 (en) | Novel compound for treatment of severe hypoglycemia | |
PH12016501184A1 (en) | Novel compound for treatment of severe hypoglycemia | |
IN2015DN00725A (es) | ||
MX2013002111A (es) | Metodos y composiciones para el tratamiento de metastasis del cancer. | |
MY171860A (en) | Method for purifying a crude pnpnh compound | |
IN2013MU03768A (es) | ||
GB201322176D0 (en) | Fuel additive composition | |
IN2015DN01285A (es) | ||
IN2015KN00386A (es) | ||
IN2013CH05395A (es) | ||
GB2507675B (en) | Fuel additive composition |